The elderly exhibit increased mortality to influenza viral infection for unclear rea- Our data demonstrate that the inoculating volume of virus is critical for adequate delivery of influenza virus to the lung and thus for efficient infection of aged mice.
virus. We found that intranasal administration of 40 µL but not 20 µL of inoculum resulted in age-dependent mortality in mice. Compared to aged mice infected with 40 µL inoculum, those infected with 20 µL inoculum showed reduced levels of live virus and IFN-β in the lung 3 days postinfection. Furthermore, aged mice administered 40 µL of Evans blue intranasally displayed increased dye retention in their bronchoalveolar lavage fluid compared to those administered 20 µL of Evans blue.
Our data demonstrate that the inoculating volume of virus is critical for adequate delivery of influenza virus to the lung and thus for efficient infection of aged mice.
These findings shed light on discrepant results in the literature regarding aged mice and influenza infection, and establish that mice can be used to examine how aging impacts the response to this biomedically important infection.
INTRODUCTION, RESU LTS, AND DISCUSSION
People over age 65 account for 90% of influenza-related deaths (Pebody et al., 2010) . Mice have been employed in hundreds of studies to examine how aging impacts the immune system (reviewed in Haynes & Swain, 2006; Nikolich-Žugich, 2018) and in aging research in general (reviewed in Vanhooren & Libert, 2013) . Discerning the mechanisms by which aging compromises the immune response to influenza in mice, and translating the findings to humans might inform on the development of novel therapies to reduce the suffering from influenza infections in the elderly.
The utility of the mice to study how aging affects influenza viral lung infection is somewhat controversial. At least five studies of either C57BL/6 mice or BALB/c mice report that aged mice (16-24 months old) display enhanced morbidity or mortality during influenza A virus (IAV) infection compared to young mice (2-4 months old), similar to humans (Steeg, 2016; Stout-Delgado, Vaughan, Shirali, Jaramillo, & Harrod, 2012; Toapanta & Ross, 2009; Wong et al., 2017; Zhao, Zhao, Legge, & Perlman, 2011) . In contrast, two studies of aged C57BL/6 mice (16-30 months old) report that aged mice exhibit reduced mortality during IAV infection compared to young mice (2-4 months old; Lu et al., 2018; Pillai et al., 2016) . Interestingly, one distinguishing feature of these two studies was the use of viral inoculum in 20 µL, whereas the studies showing that aged mice succumb faster to IAV infection employed a viral inoculum in at least 30 µL. Additionally, a prior report in young mice showed that inoculating doses of virus <35 µL led to reduced mortality to the same dose of IAV (Miller, Kok, & Li, 2013) .
Given these differences, we reasoned that the volume for the viral inoculum could explain the discrepancy between the studies of aged mice.
To test this hypothesis, we infected young (2-4 months) and aged (18 months F I G U R E 1 Volume of viral inoculum is critical for eliciting an age-dependent mortality during IAV infection. Young (2-4 months of age) and aged (18 months of age) C57BL/6 male (a, b) or female (c, d) mice were infected i.n. with either 20 µL or 40 µL inoculum of virus containing 1 x 10 4 PFU of PR8 strain IAV, and mortality was monitored. In both sexes, an age-dependent increase in mortality was only noted with the 40 µL inoculum. Overall, our study demonstrates that mice display an age-dependent acceleration of mortality to IAV infection when the viral inoculum is in 40 µL. We found that using viral inoculum in a 20 µL volume will inadequately infect lung tissue, particularly for aged mice, confounding analyses. Although factors such as strain of virus, mouse strain, method of anesthesia, and route of administration of virus (i.n., or intratracheal) could also contribute to the variation across studies that use aged mice to study IAV infection, our study highlights the importance of the volume of viral inoculum. Upon administration of IAV in 40 µL, mice exhibit an age-dependent increase in mortality similar to the clinical phenotype in humans.
Therefore, our study confirms that mice are useful to model human aging and the outcomes to IAV infection.
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